Saturday 17 October 2026
Export IVA’s income statement to Excel — free account
Inventiva S.A. Sponsored ADR
Inventiva S.A. Sponsored ADR’s revenue for fiscal 2025 (year ended December 2025) was $9.0 million, down 43.7% from fiscal 2024.
2.94
0.17
−5.47%
Follow IVA
| Older periods | Jun '23 | Jun '24 | Jun '25 | Jun '26 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
0.00 | — | — | — |
P/S ratio |
10.73 | — | — | — | |
P/FCF ratio |
0.00 | — | — | — | |
P/Operating CF |
(4.27) | — | — | — | |
P/B ratio |
0.00 | — | — | — | |
Price to Tangible BV |
0.00 | — | — | — | |
EV/Sales |
10.94 | — | — | — | |
EV/EBITDA |
0.00 | — | — | — | |
EV/Operating CF |
(1.68) | — | — | — | |
EV/FCF |
(1.67) | — | — | — | |
Quick Ratio |
1.00 | 0.28 | 2.29 | 2.68 | |
Current Ratio |
1.39 | 0.59 | 2.96 | 3.81 | |
Net Debt/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | |
Debt/Assets |
49.61% | 133.34% | 31.93% | 26.54% | |
Debt/Equity |
(4.58) | (0.66) | (6.41) | 1.13 | |
Asset Turnover |
0.18 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.82 | 0.00 | 0.00 | — | |
Capex/Depreciation |
0.00 | (0.09) | (0.01) | — | |
Interest Coverage |
0.00 | — | — | — | |
Research and Development Expense of Revenue |
2,788.06% | — | — | — | |
Selling, General and Administrative Expense of Revenue |
389.95% | — | — | — | |
Intangible Assets out of Total Assets |
0.01 | 0.01 | 0.00 | 0.00 | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | — | |
Graham Net Nets |
(0.14) | — | — | — | |
Graham Number |
3.59 | — | — | — | |
Earnings Yield |
(88.19%) | — | — | — | |
Free Cash Flow Yield |
(61.12%) | — | — | — | |
Revenue per Share |
0.04 | — | — | — | |
Operating CF per Share |
(0.95) | 0.00 | 0.00 | — | |
Capex per Share |
0.00 | 0.00 | 0.00 | — | |
Free Cash Flow per Share |
0.00 | 0.00 | 0.00 | — | |
Cash per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Shareholders Equity per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Free Cash Flow |
(0.11) | (52.24) | (61.05) | — | |
Working Capital |
15.89 | (21.04) | 129.81 | 210.89 | |
Capital Expenditures |
(0.11) | (0.18) | (0.06) | — | |
Net Current Asset Value |
(28.48) | (96.79) | (17.09) | 62.50 | |
EV/EBIT |
0.00 | — | — | — | |
Capex to Sales |
0.00 | 0.00 | 0.00 | — | |
Price to Operating Income |
0.00 | — | — | — | |
| Other line items | |||||
Average Receivables |
5.38 | 8.48 | 10.19 | 8.93 | |
Average Payables |
21.78 | 27.99 | 27.12 | 30.37 | |
Average Inventory |
0.48 | 0.41 | — | — | |
Average Assets |
109.23 | 90.11 | 157.86 | 207.60 | |
Average Common Equity |
49.15 | 7.49 | 31.09 | 58.34 |
Columns are period end dates · fundamentals updated 30 Sep 2026